Leticia Oliveira-Ferrer

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Amelie Limburg, Xueqian Qian, Bernice Brechtefeld, Nina Hedemann, Inken Flörkemeier, Christoph Rogmans, Leticia Oliveira-Ferrer, Nicolai Maass, Norbert Arnold, Dirk Olaf Bauerschlag, Jörg Paul Weimer
Generation of a Specific Fluorescence In Situ Hybridization Test for the Detection of Ovarian Carcinoma Cells. Biomedicines 12 (6) (2024)
Amelie Limburg, Xueqian Qian, Bernice Brechtefeld, Nina Hedemann, Inken Flörkemeier, Christoph Rogmans, Leticia Oliveira-Ferrer, Nicolai Maass, Norbert Arnold, Dirk Olaf Bauerschlag, Jörg Paul Weimer
Generation of a Specific Fluorescence In Situ Hybridization Test for the Detection of Ovarian Carcinoma Cells. Biomedicines 12 (6) (2024)
Fabienne Hamester, Christine Stürken, Karen Legler, Kathrin Eylmann, Katrin Möller, Maila Roßberg, Christian Gorzelanny, Alexander T Bauer, Sabine Windhorst, Barbara Schmalfeldt, Elena Laakmann, Volkmar Mueller, Isabell Witzel, Leticia Oliveira-Ferrer
Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer. Cells 11 (20) (2022)
Leticia Oliveira-Ferrer, Barbara Schmalfeldt, Johannes Dietl, Catharina Bartmann, Udo Schumacher, Christine Stürken
Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients. Biomedicines 10 (11) (2022)
Maha Elazezy, Katharina Prieske, Lan Kluwe, Leticia Oliveira-Ferrer, Sven Peine, Volkmar Müller, Linn Woelber, Barbara Schmalfeldt, Klaus Pantel, Simon A Joosse
BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer. Molecular oncology 15 (12) (2021)
Yi Ding, Vera Labitzky, Karen Legler, Minyue Qi, Udo Schumacher, Barbara Schmalfeldt, Christine Stürken, Leticia Oliveira-Ferrer
Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer. Molecular oncology 15 (12) (2021)
Leticia Oliveira-Ferrer, Roshni Goswami, Vladimir Galatenko, Yi Ding, Kathrin Eylmann, Karen Legler, Sascha Kürti, Barbara Schmalfeldt, Karin Milde-Langosch
Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients. Disease markers 2018 (2018)

Leticia Oliveira-Ferrer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Leticia Oliveira-Ferrer